SM-102 is an ionizable amino lipid that has been used in combination with other lipids in the formation of lipid nanoparticles. Administration of luciferase mRNA in SM-102-containing lipid nanoparticles induces hepatic luciferase expression in mice.
Formulations containing SM-102 have been used in the development of lipid nanoparticles for delivery of mRNA-based vaccines.
From the Connecticut government reveals that the Moderna mRNA vaccine contains an ingredient known as “SM-102,” which is well documented to be toxic to humans and animals.
Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application,
Interview with Stew Peters, Karen Kingston, a former Pfizer employee and current analyst for the pharmaceutical and medical device industries.
Censorship has caused support for ourfundraising campaign to drop drastically.If you like what we do then please help us tokeep doing it by supporting us today.